Role of entacapone in later Parkinson's disease not yet established.
作者信息
Wheatley K, Ives N, Gray R, Clarke C
出版信息
J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1081.
Abstract
摘要
相似文献
1
Role of entacapone in later Parkinson's disease not yet established.
J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):1081.
2
Entacapone in the management of Parkinson's disease.
Expert Opin Pharmacother. 2002 Jul;3(7):957-63. doi: 10.1517/14656566.3.7.957.
3
The use of entacapone in patients with advanced Parkinson's disease: 2 years' experience.
Neurol Sci. 2003 Oct;24(3):197-8. doi: 10.1007/s10072-003-0128-9.
4
Effect of levodopa and entacapone treatment on plasma homocysteine levels in Parkinson's disease patients.
Parkinsonism Relat Disord. 2009 Jul;15(6):477-8. doi: 10.1016/j.parkreldis.2008.10.005. Epub 2008 Nov 22.
5
Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease.
Arch Neurol. 2004 Oct;61(10):1563-8. doi: 10.1001/archneur.61.10.1563.
6
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment.
Eur Neurol. 2005;53(4):197-202. doi: 10.1159/000086479. Epub 2005 Jun 20.
7
[Entacapone: is it useful as complimentary treatment with levodopa?].
Rev Neurol. 1999;28(8):817-34.
8
The role of entacapone in the management of Parkinson's disease.
Hosp Med. 2000 Apr;61(4):267-71. doi: 10.12968/hosp.2000.61.4.1315.
9
[Optimization of use of levodopa in Parkinson's disease: role of levodopa-carbidopa-entacapone combination].
Neurologia. 2005 May;20(4):180-8.
10
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-off.
J Neural Transm (Vienna). 2015 Dec;122(12):1709-14. doi: 10.1007/s00702-015-1449-6. Epub 2015 Sep 7.
Zotero 插件